Next Article in Journal
Anti-Anaphylactic Activity of Isoquercitrin (Quercetin-3-O-β-d-Glucose) in the Cardiovascular System of Animals
Previous Article in Journal
Synthesis and In Vitro Photodynamic Activity of Cationic Boron Dipyrromethene-Based Photosensitizers Against Methicillin-Resistant Staphylococcus aureus
Open AccessArticle

Identification of Novel Native Autoantigens in Rheumatoid Arthritis

1
Department of Health Science and Technology, Aalborg University, 9220 Aalborg, Denmark
2
Sino-Danish Center for Education and Research, University of Chinese Academy of Sciences, 380 Huaibeizhuang, Huairou district, Beijing 100049, China
3
Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Rigshospitalet, 2100 Copenhagen, Denmark
4
Department of Clinical Immunology, Aalborg University Hospital, 9000 Aalborg, Denmark
5
Department of Clinical Medicine, Aalborg University, 9000 Aalborg, Denmark
6
Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
7
Department of Integrative Biomedical Sciences & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7700, South Africa
8
Sengenics Corporation Pte Ltd., Singapore 409051, Singapore
*
Authors to whom correspondence should be addressed.
Biomedicines 2020, 8(6), 141; https://doi.org/10.3390/biomedicines8060141
Received: 13 May 2020 / Accepted: 27 May 2020 / Published: 29 May 2020
The majority of patients diagnosed with rheumatoid arthritis (RA) have developed autoantibodies against neoepitopes in proteins that have undergone post-translational modification, e.g., citrullination or carbamylation. There is growing evidence of their molecular relevance and their potential utility to improve diagnosis, patient stratification, and prognosis for precision medicine. Autoantibodies reacting to native proteins may also have a role in RA pathogenesis, however, their reactivity patterns remain much less studied. We hypothesized that a high-density protein array technology could shed light onto the normal and disease-related autoantibodies produced in healthy and RA patient subgroups. In an exploratory study, we investigated the global reactivity of autoantibodies in plasma pools from 15 anti-cyclic citrullinated peptide (CCP)-positive and 10 anti-CCP-negative RA patients and 10 healthy donors against more than 1600 native and unmodified human proteins using a high-density protein array. A total of 102 proteins recognized by IgG autoantibodies were identified, hereof 86 were recognized by antibodies from CCP-positive RA patients and 76 from anti-CCP-negative RA patients, but not by antibodies from healthy donors. Twenty-four of the identified autoantigens have previously been identified in synovial fluid. Multiple human proteins in their native conformation are recognized by autoantibodies from anti-CCP-positive as well as anti-CCP-negative RA patients. View Full-Text
Keywords: protein array; rheumatoid arthritis; autoantibodies; native autoantigens; immunome; microarray protein array; rheumatoid arthritis; autoantibodies; native autoantigens; immunome; microarray
Show Figures

Figure 1

MDPI and ACS Style

Poulsen, T.B.G.; Damgaard, D.; Jørgensen, M.M.; Senolt, L.; Blackburn, J.M.; Nielsen, C.H.; Stensballe, A. Identification of Novel Native Autoantigens in Rheumatoid Arthritis. Biomedicines 2020, 8, 141.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop